Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports Spanish flu involves 2 relevant journals, 1 Conference , 1 Societies, 8 Collaborations, 1 Media Partners and 83 National symposiums are presently dedicated exclusively to Spanish flu and about 19 open access articles and 108 Conference Proceedings are being published on Spanish flu .
The Spanish Flu is one of the deadliest influenza pandemics to have ever occurred in documented history. During March 1918, Spanish flu spread quickly, killing an estimated 50 million to 100 million people around the world. In 1918, the flu mutated into something much more virulent . The Flu virus targeted to young and healthy, being particularly deadly to 20 to 35 year olds. This deadly flu spread quickly around the world, infecting hundreds of millions of people and killing upwards of 5 percent of the world's population. Till the date the Spanish flu pandemic origin, and the relationship between the near-simultaneous outbreaks in humans and swine , have been controversial. In 2013, AIR’s Research and Modeling Group characterizes the historic 1918 pandemic and estimates the effects of a similar pandemic occurring today using the AIR Pandemic Flu Model . In the model, "a modern day “Spanish flu” event would result in additional life insurance losses of between USD 15.3– 27.8 billion in the United States alone" with 188,000–337,000 deaths in the United States.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
The Spanish flu Conference addressed the Interventions for human seasonal, zoonotic and pandemic influenza viruses, vaccine efficacy, novel vaccination strategies and novel antiviral drugs. This conference sets the platform research for preclinical, clinical and post-licensure studies with academics and industry people.
The Spanish Flu is one of the deadliest influenza pandemics to have ever occurred in documented history. The pandemic lasted from 1918 to 1920, and coincided with World War I. The Spanish Flu was unique in that most of its victims were young healthy adults as opposed to the commonly accepted at risk groups, i.e., the elderly and children.
The symptoms of Spanish flu were quite different from the seasonal flu symptoms and as a result many of the cases were initially misdiagnosed as malaria, dengue or cholera. It infected around 500 million people globally, and killed 50 to 100 million three to five percent of the world's population.
The origin of the virus is not exactly known and its genetic makeup has been reconstructed using genetic material in frozen victims. The virus is thought to have arisen via a series of events that enabled it to spread from birds to humans. The exact points are not known and many still speculate that the virus passed through swine before evolving into the killer that it became. The fact that the virus arose in animals highlights the importance of monitoring wildlife to prevent further such pandemics.
Market Analysis:
The market of Flu consists of products to prevent, treat, and diagnose influenza viruses during both seasonal and pandemic episodes. Also included in the market is the stockpiling efforts and spending on new vaccine/therapeutic contracts. The global influenza market will grow from nearly $3.8 billion in 2012 to $4 billion in 2013. Global influenza market to be worth $6.3 billion in 2014 for a compound annual growth rate (CAGR) of 2.7%.This year, the global market for products used in the fight against influenza will be worth an estimated $5.5 billion, according to a new technical market research report, the Global Influenza Market, from BCC Research.
International symposium and workshops
Options IX for the Control of Influenza Conference, August 24 - 28 2016, Chicago, USA.
8th Asian Congress of Pediatric Infectious Diseases, November 07-10, 2016. Thailand
5th International Influenza Meeting, September 25-27, 2016, Germany.
List of Best International Conferences:
2nd Flu Conference
November 17-19, 2016 San Francisco, USA.
2nd Influenza Conference
September 12-14, 2016 Berlin, Germany.
H1N1 & Influenza Vaccines Conference
July 18-20, 2016 Chicago, USA.
7th Virology Congress
November 21-23, 2016 Baltimore, USA.
10th Euro Vaccines & Vaccination Summit
June 16-18, 2016 Rome, Italy.
2nd Retroviruses and Novel Drugs Conferences
June 30-July 1, 2016 Capetown, South Africa.
Tarvel Medicine and Vaccines Conferences
August 1-2, 2016 Seattle, USA.
2nd Respiratory and Pulmonary Medicine Conference
May 09-10, 2016 Chicago, USA.
4th Lung & Respiratory Care Conference
August 01-03, 2016 Manchester, UK.
4th Immunology Conference
October 24-26, 2016, Chicago, USA.
11th Vaccines & Vaccination Summit
September 12-14, 2016, Pheonix, USA.
7th Middle East Vaccines & Vaccination Summit
September 28-30, 2015 at Dubai, UAE.
4th Bacteriology and Infectious Diseases Congress
May 16-18, 2016 San Antonio, USA.
2nd Infectious Diseases Congress,
August 25-27, 2016 Philadelphia, USA.
13th Asia Pacific Vaccines & Vaccination Summit
November 10-12, 2016 Melbourne, Australia.
3rd Chronic Obstructive Pulmonary Disease Conference
July 11-12, 2016, Brisbane, Australia.
Trauma & Critical Care Congress
March 07-09, 2016 Madrid, Spain.
4th Epidemiology and Public Health Conference
October 03-05, 2016 London, UK.
5th Occupational Health & Safety Conference
June 06-07, 2016 Dallas, USA.
Children Vaccines Conference
October 10-12, 2016 Rome, Italy.
Relevant Society and Associations
This page will be updated regularly.
This page was last updated on November 5, 2024
